GCP
NMTR

GSA Capital Partners’s 9 Meters Biopharma NMTR Stock Holding History

GSA Capital Partners’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-109,685
Closed -$138K – 2048
2022
Q4 		$138K Sell
109,685
-7,729
-7% -$17.6K 0.02% 1264
2022
Q3 		$505K Buy
117,414
+93,954
+400% +$466K 0.07% 563
2022
Q2 		$122K Buy
23,460
+2,467
+12% +$23.2K 0.02% 1186
2022
Q1 		$252K Sell
20,993
-3,796
-15% -$51.8K 0.03% 1027
2021
Q4 		$485K Buy
24,789
+24,084
+3,416% +$539K 0.06% 617
2021
Q3 		$18K Buy
+705
New +$16.6K ﹤0.01% 1363
2021
Q1 		– Sell
-1,130
Closed -$19K – 1605
2020
Q4 		$19K Buy
+1,130
New +$18.9K ﹤0.01% 1149
2019
Q3 		– Sell
-3,239
Closed -$75K – 1796
2019
Q2 		$75K Buy
3,239
+1,209
+60% +$36.3K 0.01% 1362
2019
Q1 		$78K Buy
2,030
+705
+53% +$30.5K 0.01% 1348
2018
Q4 		$61K Buy
+1,325
New +$98.2K 0.01% 1256

Other funds holding NMTR

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ODFS
O'Donnell Financial Services San Rafael, California $290M AUM 15.6% 1-Year Est. Return
CIBC Asset Management
CIBC Asset Management Toronto, Ontario, Canada $40.9B AUM 35.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

GSA Capital Partners's NMTR Position: Q1 2023 in Review

GSA Capital Partners sold out of 9 Meters Biopharma (NMTR) in Q1 2023, closing a stake of 109,685 shares — an estimated $138K sold.

GSA Capital Partners first reported a position in NMTR in Q4 2018 and held it in 10 quarters. The position peaked at $505K in Q3 2022. 39 funds tracked by Wall St. Rank hold NMTR as of Q1 2023.

  • GSA Capital Partners reported no remaining 9 Meters Biopharma position as of Q1 2023 after selling out during the quarter.
  • GSA Capital Partners sold 109,685 9 Meters Biopharma shares in Q1 2023, an estimated $138K.
  • GSA Capital Partners first reported a position in 9 Meters Biopharma in Q4 2018 and held it in 10 quarters.
  • GSA Capital Partners's 9 Meters Biopharma position peaked at $505K in Q3 2022.
  • 39 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q1 2023.

Based on GSA Capital Partners's 13F filing for Q1 2023, filed 12 May 2023.